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Abstract At a concentration of 5U1039 M of hemi-methylat-
ed DNA (one order of magnitude below the Km), MCF-7 (a
human breast carcinoma cell line) nuclear extracts potentiate
the activity of 5-methylcytosine DNA glycosylase (5-MCDG,
alias G/T mismatch DNA glycosylase). Depending on the ratio
between MCF-7 nuclear extracts and 5-MCDG, there is an up
to 10-fold increase in 5-MCDG activity. The potentiation of
5-MCDG by MCF-7 nuclear extracts requires an estradiol re-
sponse element adjacent to the hemi-methylated site. Depletion
of the estradiol receptor from MCF-7 nuclear extracts with
speci¢c antibodies abolishes the potentiation of 5-MCDG activ-
ity. The estradiol receptor present in MCF-7 nuclear extracts
can be precipitated with antibodies directed against 5-MCDG.
Reciprocally, antibodies directed against the estradiol receptor
precipitate 5-MCDG. The results indicate the formation of a
complex between the estradiol receptor and 5-MCDG. . 2002
Federation of European Biochemical Societies. Published by
Elsevier Science B.V. All rights reserved.
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1. Introduction
It has been shown that throughout vertebrate development
there are dynamic changes in DNA methylation responsible
for the establishment of speci¢c methylation patterns [1,2]. In
terminally di¡erentiated cells, hormones can trigger changes
in chromatin structure and DNA methylation of speci¢c
genes. For example, a single injection of estradiol given to
immature chickens leads to the demethylation of the promoter
region and the activation of the hepatic vitellogenin gene [3,4].
Similarly, in hepatoma cells, glucocorticoids induce DNA de-
methylation of the promoter region and the activation of the
tyrosine aminotransferase gene [5,6]. In both cases, the local
demethylation of the target gene promoters creates a priming
and a developmental gene memory for subsequent hormone
responses [3^6]. While studying the mechanisms of hormone-
dependent DNA demethylation we observed that overexpres-
sion of 5-methylcytosine DNA glycosylase (5-MCDG) in hu-
man kidney cells resulted in the demethylation of an enhancer
region composed of tandem repeats of retinoid receptor bind-
ing sites [7]. In these cells the retinoid receptor was physically
associated with 5-MCDG (G/T mismatch DNA glycosylase).
Such an association has already been described by others [8].
Similarly we show here, in vitro, that the estradiol receptor
associates with 5-MCDG and potentiates the activity of the
glycosylase only when the DNA substrate concentration is
below the Km.
2. Materials and methods
2.1. Assay of 5-MCDG
5-MCDG was tested as previously described [9]. MCF-7 nuclear
extract and recombinant human 5-MCDG (alias G/T mismatch
DNA glycosylase, EMBL, accession number U51166) were pre-incu-
bated for 30 min on ice before the addition of the labeled DNA
substrate. The concentration of the hemi-methylated substrate was
5U1039 M (below the Km of 5-MCDG which is 8U1038 M). After
30 min incubation at 37‡C, samples were diluted to 150 Wl with water
and treated with 25 Wg proteinase K for 15 min. After phenol and
chloroform extractions, samples were precipitated with ethanol. The
sediments were dissolved in 10 Wl 0.1 M NaOH, and hydrolyzed for
3 min at 95‡C. After addition of 10 Wl formamide loading dye, sam-
ples were heated for 1 min at 95‡C and loaded onto a 20% polyac-
rylamide DNA sequencing gel. Table 1 shows the synthetic oligonu-
cleotides used in the experiments.
2.2. Preparation of nuclear extracts from MCF-7 and HeLa cells
MCF-7 cells are derived from human breast carcinoma and contain
high levels of the estradiol receptor whereas HeLa cells, a human
uterine cervical carcinoma cell line, has no traces of the estradiol
receptor. Nuclear extracts were prepared from semi-con£uent cells
using nuclear and cytoplasmic extraction reagents from Pierce. Alter-
natively, cells were fractionated as previously described [10].
The estradiol binding assay was carried out essentially as described
by Best-Belpomme et al. [11].
2.3. Immunoprecipitations and Western blots
Speci¢c antibody (1 Wl) was added to a total reaction volume of 100
Wl containing either 20 Wg MCF-7 nuclear extract or 20 Wg MCF-7
extracts pre-incubated on ice for 30 min with 0.25^2 Wg of recombi-
nant 5-MCDG. For the estradiol receptor we used a mixture of the
three monoclonal antibodies AER311 and AER314 from Serotec, and
NCL-ER-6711 from Novocastra Laboratories. The monoclonal anti-
body speci¢c for G/T mismatch DNA glycosylase (5-MCDG) was
YOHGL 2/99 from Serotec. The parallel controls received the same
amounts of non-immune IgG. After 1^2 h incubation at 4‡C, 1 Wl of
the second antibody (anti-mouse IgG) was added and the incubation
continued on ice for 1 h. The immunoprecipitates were collected by
centrifugation through a cushion of 400 Wl 1 M sucrose prepared in
phosphate-bu¡ered saline containing 1% Triton. The centrifugation
was for 20 min at 15 000Ug. The tubes were frozen in liquid nitrogen
and the tips cut o¡ and collected. The immunoprecipitates were either
counted for radioactivity or further processed for immunoblots. For
the immunoblots, the monoclonal antibodies were diluted according
to the recommendations of the manufacturer. In speci¢c cases the
supernatant fractions were further incubated with the labeled DNA
substrate and tested for 5-MCDG activity.
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2.4. Chemicals
[Q-32P]ATP 3000 Ci/mmol and [2,4,6,7-3H]17L-estradiol 120 Ci/
mmol were obtained from Amersham. All oligonucleotides (methylat-
ed and non-methylated) were synthesized by Microsynth (Balgach,
Switzerland).
3. Results
3.1. Nuclear extracts from MCF-7 cells potentiate the activity
of 5-MCDG
At a concentration of hemi-methylated nucleotide below the
Km, MCF-7 nuclear extracts potentiated the activity of
5-MCDG. The potentiation was only observed at a speci¢c
ratio of MCF-7 nuclear extracts to 5-MCDG. Fig. 1 shows a
titration curve of a constant amount of MCF-7 nuclear ex-
tract (20 Wg) with increasing concentrations of 5-MCDG. The
maximum stimulation is observed with 1 Wg 5-MCDG (Figs. 1
and 2A, lanes 1 and 2). One of the possible reasons why is
there a drop in 5-MCDG activity at higher concentrations of
recombinant 5-MCDG may be due to the presence of some
inhibitory bacterial proteins present in the preparation. As
evidence for it, we tested di¡erent preparations of the re-
combinant 5-MCDG containing less bacterial protein (puri-
¢ed twice by a⁄nity chromatography). These preparations
gave a less prominent drop in activity when incubated at high-
er concentrations (results not shown). Similar results were
obtained for G/T mismatch glycosylase while using oligonu-
cleotide D from Table 1 (results not shown). MCF-7 extracts
incubated alone with the hemi-methylated oligonucleotides
showed only non-speci¢c degradation of the substrate but
no traces of the glycosylase activity (lane 3), thus excluding
an additive e¡ect between MCF-7 and 5-MCDG. The poten-
tiation by MCF-7 nuclear extracts requires an estradiol re-
Fig. 1. Potentiation of 5-MCDG activity by MCF-7 nuclear ex-
tracts. A constant amount of MCF-7 nuclear extract (20 Wg) was ti-
trated with increasing concentrations of recombinant 5-MCDG pro-
duced in bacteria. The S.E.M. for each concentration point is about
R 3% (three or four measurements per point).
Fig. 2. Interaction between MCF-7 nuclear extracts and 5-MCDG. The reaction product was analyzed on a 20% polyacrylamide sequencing
gel. The arrowhead shows the position of the reaction product of the glycosylase. In A the oligonucleotide substrate (oligonucleotide A) has an
estradiol response element (ERE) and a methylated CpG. In B, the substrate has no ERE (oligonucleotide C) but one methylated CpG. In C,
the substrate is oligonucleotide A but MCF-7 nuclear extracts have been replaced by HeLa extracts. Lanes 1 are the substrates incubated with
5-MCDG alone. Lanes 2 combine 5-MCDG with either MCF-7 nuclear extracts which contain estradiol receptors or HeLa nuclear extracts
(which have no estradiol receptor). Lanes 3 are either MCF-7 or HeLa nuclear extracts incubated alone with the DNA substrate. Lanes 4 are
the controls with DNA alone.
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sponse element GGTCAxxxTGACC present in the vicinity of
the hemi-methylated CpG site. Fig. 2B clearly shows that in
the absence of the estradiol response element (oligonucleotides
B or C from Table 1) there is no potentiation of 5-MCDG by
MCF-7 nuclear extracts (Fig. 2B, compare lanes 1 and 2).
These results indicate that the potentiation of 5-MCDG by
MCF-7 nuclear extract may require the estradiol receptor.
When 5-MCDG is incubated with an oligonucleotide duplex
containing an estradiol response element but with a human
cell extract devoid of the estradiol receptor (such as HeLa cell
nuclear extracts), no potentiation takes place (Fig. 2C, com-
pare lanes 1 and 2). Taken together, these results strongly
indicate that the estradiol receptor may be responsible for
the potentiation of 5-MCDG activity.
3.2. The estradiol receptor present in MCF-7 nuclear extracts
is responsible for the in vitro stimulation of 5-MCDG
Preliminary experiments indicated that monoclonal anti-
bodies against the human estradiol receptor could form a
complex with the native receptor without inhibiting the po-
tentiation of 5-MCDG activity. Consequently, it was neces-
sary to ¢rst deplete the MCF-7 extracts of the estradiol re-
ceptor and then incubate them with 5-MCDG. This was
achieved as outlined in Section 2. The results given in Fig. 3
(compare lanes 2 and 3) clearly show that after depletion of
the estradiol receptor from MCF-7 nuclear extract, no poten-
tiation of 5-MCDG took place. There is, however, a higher
background for lanes 4 and 5 of Fig. 3 than for lane 3. This is
not due to a longer exposure time of the autoradiograms. As
seen in lane 5 an incubation of the labeled substrate with
MCF-7 nuclear extracts gives a background of non-speci¢c
degradation. When the complex of MCF-7 and 5-MCDG is
precipitated with antibody against the estradiol receptor and
sedimented through sucrose there is less DNase present in the
supernatant fraction. In contrast, in the absence of precipita-
tion (non-immune serum) there is a higher level of non-spe-
ci¢c degradation of the substrate. Further tests indicated that
the stimulation of 5-MCDG by MCF-7 nuclear extracts did
not require the presence of 17L-estradiol and that a recombi-
nant estradiol receptor produced in bacteria was far less po-
tent than the estradiol receptor present in nuclear extracts
from MCF-7 cells (data not shown).
3.3. 5-MCDG is physically associated with the estradiol
receptor
As a ¢rst test for a possible association of the estradiol
receptor with 5-MCDG, the estradiol receptor present in
MCF-7 nuclear extracts was labeled with 1038 M [3H]17L-
estradiol and further incubated with increasing concentrations
Table 1
Sequences of the oligonucleotides used as substrates (only the meth-
ylated strand is shown)
Oligonucleotide A contains an estradiol response element (ERE)
next to the methylated CpG. Oligonucleotides B and C have one
methylated CpG but no ERE. Oligonucleotide D has one ERE and
one G/T mismatch (underlined).
Fig. 3. E¡ect of a depletion of the estradiol receptor from MCF-7
nuclear extracts on the activity of 5-MCDG. The reaction product
was analyzed on a 20% polyacrylamide sequencing gel. The arrow-
head shows the position of the reaction product of the glycosylase.
Lane 1 is the DNA substrate incubated alone. In lane 2, 5-MCDG
is incubated alone with substrate A. In lane 3, MCF-7 nuclear ex-
tract has been treated with antibodies against the estradiol receptor
and incubated with 5-MCDG and substrate A. Lane 4 is the same
as lane 3 except that the MCF-7 nuclear extracts were treated with
non-immune IgG. Lane 5 is a control of non-treated MCF-7 nu-
clear extracts incubated with DNA substrate A.
Fig. 4. Precipitation of [3H]estradiol-labeled MCF-7 nuclear extracts
with antibodies against 5-MCDG (G/T mismatch DNA glycosylase).
The solid and dotted lines represent the precipitation of [3H]estra-
diol-labeled MCF-7 and HeLa nuclear extracts respectively. Experi-
ments were carried out as outlined in Section 3. A constant amount
of labeled nuclear extract (20 Wg) was titrated with increasing con-
centrations of recombinant human 5-MCDG. The average S.E.M.
for each concentration point is about R 5% (average of three mea-
surements).
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of recombinant 5-MCDG. After 1 h incubation on ice to
allow the formation of a complex, the reaction mixture was
immunoprecipitated with antibodies against 5-MCDG as out-
lined in Section 2. Fig. 4 shows that an estradiol binding
protein (presumably the estradiol receptor) co-precipitated
with 5-MCDG. The same experiment repeated with HeLa
nuclear extracts which have no estradiol receptor gave no
precipitate (dotted line of Fig. 4).
The immunoprecipitates were further characterized by
Western blots. Fig. 5 (left hand panel) shows that the protein
that co-precipitates with 5-MCDG is indeed the estradiol re-
ceptor. The reciprocal immunoprecipitation was carried out
with antibodies against the estradiol receptor. Fig. 5 (right
hand panel) shows that the protein which co-precipitates
with the estradiol receptor is 5-MCDG.
4. Discussion
We have previously shown that 5-MCDG and G/T mis-
match DNA glycosylase activities share the same protein
[12]. We also know that this protein can associate with the
retinoic acid receptor [7,8]. Such an association has been
shown, in kidney cells, to be instrumental for the selective
demethylation of a methylated transgene containing repeats
of retinoic acid receptor binding sites [7]. Our present results
also indicate that the association of the estradiol receptor with
5-MCDG may explain the speci¢c targeting of DNA demeth-
ylation by estradiol-controlled genes. As we have previously
observed, in vivo demethylation of the estradiol-controlled
vitellogenin gene starts in the vicinity of the estradiol response
element [4] and an association of 5-MCDG with the estradiol
receptor could possibly target this reaction more precisely.
Concomitant with the demethylation reaction of the vitelloge-
nin promoter, there are also changes in chromatin structure
[13^15]. Since the same protein has so far two di¡erent cata-
lytic functions (the removal of 5-methylcytosine and the cor-
rection of G/T mismatches) it is conceivable that the two
reactions also share the same enzymes (AP lyase, DNA poly-
merase L, and DNA ligase) as the heterochromatin opens up
and becomes associated with transcription factors. In addi-
tion, one cannot exclude the possibility that 5-MCDG (alias
G/T mismatch DNA glycosylase) may also be part of the
transcription machinery. For example, it has been shown re-
cently that G/T mismatch DNA glycosylase associates with
the transcription coactivators CMP and p300 acetylase [16].
In this system, G/T mismatch DNA glycosylase stimulates
CBP transcriptional activity in transfected cells and serves
as a substrate for CBP/p300 acetylation [16]. On the other
hand, the estradiol receptor can be associated with other pro-
teins, causing alterations of large-scale chromatin structures
[17]. In this context it is not surprising that 5-MCDG (alias
G/T mismatch DNA glycosylase) associates with the estradiol
receptor forming a complex that could selectively target DNA
repair and demethylation of genes in an open structure of
chromatin.
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Fig. 5. Immunoprecipitation and Western blot of the estradiol re-
ceptor^5-MCDG complex. In the left hand panel the precipitation
of the complex was carried out with anti-G/T mismatch DNA gly-
cosylase and the Western blot was carried out with estradiol recep-
tor antibody. In the right hand panel, the precipitation was done
with an antibody against the estradiol receptor and the Western
blot carried out with an antibody against G/T mismatch DNA gly-
cosylase. Lanes 1 are the molecular weight size markers. The speci¢c
immunoprecipitations are shown in lanes 2. In lanes 3 the immuno-
precipitation was carried out with non-immune reacting IgG.
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